Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,237 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06033300Recruiting
Blood cell clumps in heparin-induced low platelets
This study looks at how blood cells clump together in patients who may have heparin-induced thrombocytopenia (HIT), a condition where heparin causes a drop in platelets. It aims to better understand the disease and improve diagnosis.
AmiensAges 18 years+ - NCT06556251Recruiting
Digital platform for early psychosis care
This study tests if a digital platform can help people with early psychosis stay engaged in treatment and improve their recovery.
Sant Boi de Llobregat, BarcelonaAges 18–40 - NCT06318780Recruiting
Comparing imaging methods to find leaks after aortic repair
This study compares three different imaging methods (dynamic CT, contrast-enhanced ultrasound, and CT angiography) to better identify and characterize endoleaks—small leaks that can happen after aortic aneurysm repair. The goal is to find the most accurate way to detect these leaks so patients can get the right treatment sooner.
Amiens, PicardieAges 18 years+ - NCT06989892Recruiting
Comparing two dialysis filters for sepsis patients
This trial tests whether a newer, higher-performing dialysis filter helps people with kidney failure and sepsis better than the standard filter. It focuses on patients with high levels of inflammation (measured by a marker called interleukin-6).
Dusit, BangkokAges 18 years+ - NCT04375280Recruiting
Study of mobility problems in people with long-term illnesses
This study observes how people with chronic health conditions affect their ability to move and do everyday activities. It may help researchers better understand mobility limits and what factors influence them.
Clermont-FerrandAges 18–90 - NCT04690660Recruiting
Study of high blood pressure after pregnancy
This study follows people who had high blood pressure during pregnancy and/or in the first two weeks after delivery. The goal is to better understand postpartum hypertension so care can be improved for mothers at higher risk.
BaselAges 18 years+ - NCT06983977Recruiting
Boosting activity for hospital patients with digital nudges
This trial tests if gentle digital reminders sent to patients and staff can help medical patients be more active while in the hospital. It aims to improve recovery by encouraging safe movement.
Copenhagen, Capital RegionAges 18 years+ - NCT06989125Recruiting
Online vs. video therapy for gambling disorder
This trial compares two types of cognitive behavioral therapy for gambling disorder: one you do online on your own schedule and one face-to-face with a therapist over video. The goal is to see which works better, so you can choose the option that fits your life.
Aarhus, DenmarkAges 18 years+ - NCT06988956RecruitingPhase 2
Nimotuzumab Plus Chemoradiation for Older Adults with Esophageal Cancer
This trial tests adding nimotuzumab, a targeted therapy, to standard chemoradiation for elderly patients with esophageal squamous cell cancer. It aims to see if the combination improves outcomes.
NanjingAges 75 years+ - NCT06988696Recruiting
Heated socks during bladder tumor surgery to prevent hypothermia
This study tests whether wearing heated socks during bladder tumor surgery helps keep your body temperature stable and your vital signs normal. Patients who are comfortable with heated socks and meet other health criteria may join.
Samsun, Atakum/SamsunAges 20–90 - NCT07046806RecruitingPhase 1/Phase 2
Oral deucrictibant for hereditary angioedema attacks
This trial tests an oral medication called deucrictibant to prevent and treat swelling attacks in people with hereditary angioedema. It may help reduce the number and severity of attacks.
Wheaton, MarylandAges 18–75 - NCT07052565Recruiting
CAR-T cell therapy for autoimmune diseases
This trial uses your own engineered immune cells (CAR-T cells) to treat severe autoimmune diseases like rheumatoid arthritis, lupus, Sjögren's syndrome, or systemic sclerosis that haven't improved with standard medicines. The goal is to see if this treatment can calm the immune system and reduce disease activity.
HefeiAges 18 years+ - NCT07047456RecruitingPhase 3
Stem cell infusion timing and graft-versus-host disease risk in blood cancer patients
This trial looks at whether the time when stem cells are infused affects the chance of developing graft-versus-host disease (aGVHD) after a cord blood transplant. It may help find the best timing to improve outcomes for people with blood cancers.
Hefei, AnhuiAges Any age - NCT07050745Recruiting
Cervical cancer screening study for women in Kenya
This study aims to make cervical cancer screening easier and more patient-friendly for women in Kenya. If you are a woman between 25 and 49, not pregnant or recently postpartum, you may be able to join.
NairobiAges 25–49 - NCT07053618Recruiting
Heart pump support for high-risk heart procedures
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
Beijing, Beijing MunicipalityAges 18–90 - NCT07051629RecruitingPhase 1
Testing a new epilepsy medicine for safety in healthy people and patients
This study tests a new medicine called SIF001 for safety. It first gives the medicine to healthy volunteers, and then to people with epilepsy who have seizures even while on their current medicines. The goal is to find a safe dose.
Tucson, ArizonaAges 18–70 - NCT07054567RecruitingPhase 2
Study of BL-B01D1 plus Keytruda for advanced cervical or endometrial cancer
This trial tests a new drug combination for people with cervical or endometrial cancer that has come back or spread. The study aims to see if adding BL-B01D1 to Keytruda (with or without Avastin) can help shrink tumors or slow the cancer's growth.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07045454RecruitingPhase 1
MHB118C shot for advanced solid tumors
This trial tests an injection called MHB118C for people with advanced solid tumors that have stopped responding to standard treatments or have no standard options. The goal is to see if this new drug can help shrink tumors or slow their growth.
ShanghaiAges 18 years+ - NCT07051707Recruiting
Study of a new lung treatment for people with COPD
This trial tests a device called dNerva that targets nerves in the lungs to help people with COPD breathe easier. It is designed for those who have moderate to severe COPD and are not currently smoking.
Birmingham, AlabamaAges 40–80 - NCT07045701Enrolling by invitationPhase 2/Phase 3
Testing FMXIN002 for food allergy reactions
This study is testing a new medicine (FMXIN002) for people who are at risk of a severe allergic reaction to food. If you have a known food allergy and have had a moderate reaction during a food challenge, you may be able to join. The trial will check if the medicine helps prevent or reduce the severity of future reactions.
Be’er Ya‘aqovAges 18–40 - NCT07046234Enrolling by invitation
Lung ultrasound for people with shortness of breath
This trial uses a portable ultrasound at the bedside (called point-of-care lung ultrasound) to quickly examine the lungs of people who are having trouble breathing. The goal is to see how well this test works for finding lung problems in the hospital or clinic.
New Haven, ConnecticutAges 22 years+ - NCT07048795Recruiting
Testing mylife CamAPS FX system in type 1 diabetes patients in France
This study tests a new automated insulin delivery system (mylife CamAPS FX) for people with type 1 diabetes. It aims to see how well the system works when paired with a Dexcom G6 continuous glucose monitor.
AmiensAges Any age - NCT07045480Recruiting
Preventing pressure ulcers with a vegetable skincare oil
This trial tests whether a vegetable skincare oil (RIVADOUCE) applied to skin areas at risk can help prevent pressure ulcers in patients staying in a care facility for at least a month. If you are at risk for pressure ulcers but don't have one yet, you may be able to join.
Multiple LocationsAges 18 years+ - NCT07051044Recruiting
Cheek swab light test for lung cancer risk
This trial uses a simple cheek swab and a special light test to look for signs of lung cancer risk. It aims to help doctors decide who needs more testing, especially if you have symptoms or are currently being checked for lung cancer.
North ShieldsAges 18 years+
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,237 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.